Rosuvastatin calcium and Aortic valve incompetence - a phase IV clinical study of FDA data

Summary:

Aortic valve incompetence is reported as a side effect among people who take Rosuvastatin calcium (rosuvastatin calcium), especially for people who are male, 60+ old, also take Amlodipine, and have High blood pressure.

The phase IV clinical study analyzes which people have Aortic valve incompetence when taking Rosuvastatin calcium. It is created by eHealthMe based on reports of 24,757 people who have side effects when taking Rosuvastatin calcium from the FDA, and is updated regularly.

What is Rosuvastatin calcium?

Rosuvastatin calcium has active ingredients of rosuvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 25,354 Rosuvastatin calcium users. Check the latest studies of Rosuvastatin calcium.

What is Aortic valve incompetence?

Aortic valve incompetence is found to be associated with 917 drugs and 881 conditions by eHealthMe. Check the latest studies of Aortic valve incompetence.

On Aug, 05, 2026

24,757 people reported to have side effects when taking Rosuvastatin calcium.
Among them, 31 people (0.13%) have Aortic valve incompetence.

Could Rosuvastatin calcium cause Aortic valve incompetence?

Among these 31 people:

What is the gender of people who have Aortic valve incompetence when taking Rosuvastatin calcium? *

female: 20.69 %
male: 79.31 %

What is the age of people who have Aortic valve incompetence when taking Rosuvastatin calcium? *

What are other drugs people take besides Rosuvastatin calcium? *

What are other side effects people have besides Aortic valve incompetence? *

Tricuspid Valve Incompetence (inefficient heart valve): 25 people, 80.65%
Mitral Valve Incompetence (inefficient heart valve): 25 people, 80.65%
Left Ventricular Hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart): 20 people, 64.52%
Cardiac Failure: 19 people, 61.29%
Diastolic Dysfunction: 17 people, 54.84%
Left Ventricular Dysfunction: 14 people, 45.16%
High Blood Pressure: 14 people, 45.16%
Dyspnea (difficult or laboured breathing): 13 people, 41.94%
Thrombocytopenia (decrease of platelets in blood): 12 people, 38.71%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 12 people, 38.71%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 38.71%
Acute Kidney Failure: 9 people, 29.03%
Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 8 people, 25.81%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 8 people, 25.81%
Carotid Arteriosclerosis (plaque deposition in artery): 7 people, 22.58%
Cardiac Failure: 7 people, 22.58%
Central Obesity (belly fat): 5 people, 16.13%
Arrhythmias (irregular heartbeat): 4 people, 12.90%
Primary Myelofibrosis (primary disorder of the bone marrow): 2 people, 6.45%
Left Ventricular Failure (left ventricle fails to contract forcefully): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Rosuvastatin calcium and have Aortic valve incompetence?

- Check whether Aortic valve incompetence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rosuvastatin calcium:

Rosuvastatin calcium (25,354 reports)

Browse all side effects of Rosuvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Aortic valve incompetence:

Aortic valve incompetence (917 drugs)

Browse all the conditions that are associated with Aortic valve incompetence:

Aortic valve incompetence (881 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rosuvastatin calcium (the active ingredients of Rosuvastatin calcium) and Rosuvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.